GO:0005009 insulin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005009 insulin receptor activity is a molecular function defined as combining with an insulin receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity.
• The insulin receptor is a ligand-activated receptor tyrosine kinase; insulin binding activates its intrinsic tyrosine kinase activity and autophosphorylation, initiating downstream signaling.
• Insulin receptor activity is central to metabolic regulation, especially in skeletal muscle, which is the paramount tissue determining glycemia.
• Dysregulated insulin receptor signaling contributes to insulin resistance, type 2 diabetes, and other metabolic disorders.
• Receptor endocytosis and trafficking dynamically regulate the strength and duration of insulin receptor signaling.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of insulin receptor activity in health and disease.
Description
GO:0005009 insulin receptor activity is a molecular function that enables a receptor to combine with an insulin receptor ligand and transmit the signal across the plasma membrane to initiate a change in cell activity. This activity is essential for metabolic homeostasis, growth, and differentiation, and it is one of the most intensively studied receptor tyrosine kinase functions in biomedical research. The insulin receptor is a ligand-activated tyrosine kinase; insulin binding triggers receptor autophosphorylation and activation of its intrinsic kinase activity, which is the first biochemical step in insulin action. Because insulin receptor activity controls glucose uptake, glycogen synthesis, and protein metabolism, its dysfunction is directly linked to insulin resistance and type 2 diabetes. In skeletal muscle, the predominant site of insulin-stimulated glucose disposal, insulin receptor activity determines whole-body glycemia. Consequently, researchers need robust experimental systems to interrogate the causal roles of the receptor and its downstream effectors. This article summarizes the definition, mechanism, key genes, disease relevance, and CRISPR-based research methods for GO:0005009 insulin receptor activity.
insulin receptor activity At A Glance
| GO ID | GO:0005009 |
|---|---|
| GO term | insulin receptor activity |
| Ontology | molecular_function |
| Synonym | insulin-activated receptor activity |
| Definition | Combining with insulin receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
| Major function | Ligand-activated receptor tyrosine kinase signaling that initiates insulin action. |
| Primary ligand | Insulin and related insulin receptor ligands. |
| Key tissue context | Skeletal muscle is the paramount tissue determining glycemia. |
| Regulatory mechanism | Receptor endocytosis and trafficking modulate signal duration. |
What Is GO:0005009?
In our own words, GO:0005009 insulin receptor activity describes the molecular function of a receptor that binds an insulin receptor ligand and, upon binding, transmits a signal across the plasma membrane to initiate a change in cell activity. This activity is synonymous with insulin-activated receptor activity and is classified under the molecular_function aspect of the Gene Ontology. It encompasses ligand recognition, receptor activation, and signal transduction, and it is typically mediated by the insulin receptor tyrosine kinase.
Why Is insulin receptor activity Important in Cell Biology?
Insulin receptor activity is important because it is the initiating molecular event for insulin action, which controls glucose homeostasis, glycogen synthesis, lipid metabolism, and protein synthesis. Defects in this activity cause insulin resistance, a hallmark of type 2 diabetes and a contributor to cardiovascular and metabolic disease. In skeletal muscle, insulin receptor activity is rate-limiting for insulin-stimulated glucose disposal, making it a central determinant of whole-body glycemia. Moreover, because the receptor is a tyrosine kinase, its activity is amenable to pharmacological and genetic manipulation, and it serves as a paradigm for understanding receptor tyrosine kinase signaling. Studying GO:0005009 therefore has direct implications for diabetes, metabolic syndrome, and cancer biology.
• Initiates insulin signaling, a core pathway in metabolic regulation.
• Controls glucose uptake and glycogen synthesis in skeletal muscle, the paramount tissue determining glycemia.
• Dysfunction causes insulin resistance and type 2 diabetes.
• Serves as a model for ligand-activated receptor tyrosine kinase mechanisms.
• Regulated by endocytosis, which tunes signal strength and duration.
• Target of de novo-designed agonists for tuning receptor signaling.
• Relevant to muscle physiology and exercise adaptation.
• Provides a therapeutic target for metabolic disease.
• Enables CRISPR-based causal gene studies in metabolic research.
• Links receptor activity to whole-body energy homeostasis.
Molecular Mechanism of insulin receptor activity
Ligand binding and receptor activation
In simple terms: Insulin binds to the receptor and switches it on.
Insulin receptor activity begins when an insulin receptor ligand binds to the extracellular domain of the receptor. This binding event transmits a signal across the plasma membrane and initiates a change in cell activity, as defined by GO:0005009. The receptor is a tyrosine kinase, and ligand binding activates its intrinsic kinase activity. De novo-designed agonists can tune insulin receptor signaling, demonstrating that ligand-receptor engagement is the primary control point.
Autophosphorylation and tyrosine kinase activation
In simple terms: The receptor adds phosphate groups to itself to become fully active.
Upon ligand binding, the insulin receptor undergoes autophosphorylation, which is required for full activation of its tyrosine kinase activity. This catalytic step is a hallmark of receptor tyrosine kinases and is essential for transmitting the insulin signal. The protein kinase activity of the insulin receptor has been characterized biochemically, confirming that autophosphorylation is an early and necessary event in insulin action.
Downstream signal transduction
In simple terms: The activated receptor passes the message to other proteins inside the cell.
Activated insulin receptor phosphorylates downstream substrate proteins, initiating signaling cascades that regulate glucose uptake, glycogen synthesis, and gene expression. In skeletal muscle, this signaling is critical for insulin-stimulated glucose disposal, and the receptor activity is the first step in that process. The tyrosine kinase activity of the receptor is directly linked to insulin action in target tissues.
Receptor endocytosis and signal termination
In simple terms: The cell internalizes the receptor to control how long the signal lasts.
Insulin receptor endocytosis dynamically regulates the strength and duration of insulin receptor activity. After activation, the receptor is internalized into endosomes, where it can be recycled or degraded, thereby modulating signal output. This trafficking step is an important regulatory node for GO:0005009 and influences cellular responsiveness to insulin.
Tissue-specific roles in skeletal muscle
In simple terms: Muscle is the main tissue where insulin receptor activity controls blood sugar.
Skeletal muscle is the paramount tissue determining glycemia, and insulin receptor activity in muscle is a major determinant of whole-body glucose homeostasis. The many actions of insulin in skeletal muscle include stimulation of glucose uptake and glycogen synthesis, all initiated by receptor activity. Human studies of insulin receptor function and glycogen synthase activity in skeletal muscle have provided pathophysiological insights into insulin resistance.
Key Genes Involved in GO:0005009 insulin receptor activity
The following genes and proteins are central to insulin receptor activity and its downstream signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Encodes the insulin receptor; mediates ligand binding and tyrosine kinase activity | Core gene for GO:0005009; target for knockout and point-mutation studies |
| INS | Encodes insulin, the primary ligand for the insulin receptor | Ligand source; relevant for agonist and overexpression studies |
| IRS1 | Insulin receptor substrate 1; downstream docking protein phosphorylated by the receptor | Key effector; knockout models reveal signaling branch points |
| IRS2 | Insulin receptor substrate 2; mediates metabolic insulin signaling | Important for liver and beta-cell function; knockout models available |
| PIK3CA | Catalytic subunit of PI3K; activated downstream of IRS proteins | Links receptor activity to glucose uptake; point-mutation models |
| AKT1 | Serine/threonine kinase; central node in insulin signaling | Readout of receptor activity; knockout and knock-in models |
| AKT2 | Insulin-responsive AKT isoform; regulates glucose metabolism | Tissue-specific knockout models for metabolic studies |
| SLC2A4 | GLUT4 glucose transporter; translocates to membrane upon insulin signaling | Functional readout of insulin receptor activity in muscle |
| GSK3A | Glycogen synthase kinase 3 alpha; regulated by insulin signaling | Links receptor activity to glycogen synthesis |
| GSK3B | Glycogen synthase kinase 3 beta; downstream of AKT | Point-mutation models for phosphorylation studies |
| GYS1 | Muscle glycogen synthase; activated by insulin signaling | Readout of insulin action in skeletal muscle |
| PTPN1 | Protein tyrosine phosphatase 1B; negative regulator of insulin receptor | Knockout models enhance insulin sensitivity |
| INSRR | Insulin receptor-related receptor; related conformational transitions | Comparative studies of receptor family dynamics |
| SHC1 | Adaptor protein; couples receptor to MAPK pathway | Knockout models for signaling specificity |
| GRB2 | Adaptor protein; links receptor to Ras-MAPK cascade | Point-mutation studies of adaptor function |
| SOS1 | Guanine nucleotide exchange factor; activated downstream of receptor | Overexpression models for pathway activation |
| HRAS | Small GTPase; downstream of receptor via GRB2-SOS | Point-mutation models for oncogenic signaling |
| MAPK1 | ERK2; terminal kinase in receptor-activated MAPK cascade | Readout of receptor activity; knockout models |
How Is insulin receptor activity Regulated?
Insulin receptor activity is regulated at multiple levels. Ligand availability and receptor affinity control the initiation of signaling. Autophosphorylation and tyrosine kinase activity are required for activation, and phosphatases such as PTPN1 negatively regulate the receptor. Receptor endocytosis and trafficking dynamically modulate signal duration and intensity. In skeletal muscle, insulin receptor activity is influenced by metabolic state and exercise, and it is coupled to glycogen synthesis. De novo-designed agonists can tune receptor signaling, indicating that the receptor is amenable to pharmacological regulation.
insulin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Insulin resistance, type 2 diabetes | Knockout and point-mutation cell models |
| IRS1 | Insulin resistance, metabolic syndrome | Knockout and overexpression models |
| AKT2 | Type 2 diabetes, lipodystrophy | Tissue-specific knockout models |
| SLC2A4 | Impaired glucose uptake in diabetes | Knock-in and tagged knock-in models |
| PTPN1 | Insulin resistance, obesity | Knockout models to enhance insulin sensitivity |
Insulin resistance and type 2 diabetes
Impaired insulin receptor activity is a central feature of insulin resistance, which precedes and accompanies type 2 diabetes. Defects in receptor function and downstream signaling reduce glucose uptake in skeletal muscle, contributing to hyperglycemia. Human studies of insulin receptor function and glycogen synthase activity in skeletal muscle have documented pathophysiological changes in insulin-resistant states.
Metabolic syndrome and cardiovascular disease
Dysregulated insulin signaling is associated with metabolic syndrome, dyslipidemia, and increased cardiovascular risk. Because insulin receptor activity controls multiple metabolic pathways, its dysfunction has systemic consequences beyond glucose homeostasis.
Cancer and cell growth
Insulin receptor signaling can influence cell growth and survival through downstream MAPK and PI3K pathways. Altered receptor activity and endocytosis may contribute to cancer biology by modulating proliferative signals. However, the precise role is context-dependent and requires further study.
Muscle metabolism and exercise
Skeletal muscle is the paramount tissue determining glycemia, and insulin receptor activity in muscle is essential for insulin-stimulated glucose disposal. Conditions affecting muscle insulin sensitivity, such as physical inactivity, can impair receptor signaling and whole-body glucose homeostasis.
From insulin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does INSR loss abolish insulin signaling? | INSR knockout cell line |
| How does a specific INSR mutation affect kinase activity? | Point-mutation knock-in of INSR |
| Where is the insulin receptor localized during signaling? | Tagged knock-in of INSR with fluorescent tag |
| Does overexpression of IRS1 enhance insulin sensitivity? | IRS1 overexpression cell model |
| Which genes modulate insulin receptor activity? | CRISPR library screening |
| How does receptor endocytosis regulate signal duration? | Knockout of endocytosis regulators |
How to Study the insulin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Tyrosine kinase activity and autophosphorylation | Validation of receptor mutants and agonists |
| Phosphoproteomics | Global phosphorylation changes downstream of receptor | Mapping signaling networks |
| Live-cell imaging | Receptor endocytosis and trafficking | Studying signal regulation |
| Glucose uptake assay | Functional glucose transport | Assessing insulin sensitivity in muscle cells |
| Western blot | Phosphorylation of receptor and substrates | Confirming pathway activation |
| CRISPR screening | Genes modulating receptor activity | Discovery of novel regulators |
| RNA-seq | Transcriptional changes upon receptor activation | Identifying downstream gene expression programs |
Biochemical kinase assays
Insulin receptor tyrosine kinase activity can be measured using in vitro kinase assays that detect autophosphorylation and substrate phosphorylation. These assays provide direct readouts of GO:0005009 and are useful for validating point mutations and designed agonists.
Phosphoproteomics and signaling profiling
Mass spectrometry-based phosphoproteomics can quantify phosphorylation events downstream of insulin receptor activation, revealing signaling networks. This approach is valuable for comparing wild-type and CRISPR-edited cells.
Live-cell imaging of receptor trafficking
Fluorescently tagged insulin receptors enable live-cell imaging of endocytosis and trafficking, which regulate signal duration. Tagged knock-in models are ideal for such studies.
Functional glucose uptake assays
Glucose uptake assays in skeletal muscle cells measure the functional consequence of insulin receptor activity. These assays link receptor function to metabolic outcomes and are used to test insulin sensitivity.
How CRISPR Can Be Used to Study GO:0005009 insulin receptor activity
Knockout
CRISPR knockout of INSR or downstream genes can abolish insulin receptor activity and reveal its causal role in signaling and metabolism. Knockout models are essential for distinguishing receptor-dependent from receptor-independent effects.
Point Mutation
Point mutations in INSR can mimic naturally occurring variants that alter kinase activity or ligand binding. These models help dissect the contribution of specific residues to receptor function and disease.
Knock-in
Knock-in of tagged or mutant INSR allows precise tracking of receptor localization and activity. Tagged knock-in models are particularly useful for imaging endocytosis and trafficking.
Overexpression
Overexpression of INSR or its ligands can amplify insulin receptor activity and downstream signaling. Such models are used to study gain-of-function effects and to test therapeutic agonists.
How EDITGENE Supports insulin receptor activity Research
Researchers studying insulin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, metabolic regulation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for insulin receptor activity research.
Frequently Asked Questions About insulin receptor activity
What is insulin receptor activity?
Insulin receptor activity (GO:0005009) is a molecular function defined as combining with an insulin receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity.
What genes are involved in insulin receptor activity?
Key genes include INSR, INS, IRS1, IRS2, PIK3CA, AKT1, AKT2, and SLC2A4, which mediate ligand binding, kinase activation, and downstream signaling.
What is the GO ID for insulin receptor activity?
The Gene Ontology ID for insulin receptor activity is GO:0005009.
How is insulin receptor activity regulated?
It is regulated by ligand binding, autophosphorylation, phosphatase activity, and receptor endocytosis.
What diseases are linked to insulin receptor activity?
Dysregulated insulin receptor activity is linked to insulin resistance, type 2 diabetes, metabolic syndrome, and potentially cancer.
What is the role of insulin receptor activity in skeletal muscle?
In skeletal muscle, insulin receptor activity initiates glucose uptake and glycogen synthesis, and muscle is the paramount tissue determining glycemia.
How can CRISPR be used to study insulin receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to dissect the causal roles of INSR and downstream genes.
What methods measure insulin receptor activity?
In vitro kinase assays, phosphoproteomics, live-cell imaging, and glucose uptake assays are commonly used.
Is insulin receptor activity a molecular function?
Yes, GO:0005009 is classified under the molecular_function aspect of the Gene Ontology.
What is the synonym for insulin receptor activity?
The synonym is insulin-activated receptor activity.
Conclusion
GO:0005009 insulin receptor activity is a fundamental molecular function that initiates insulin signaling and controls metabolic homeostasis. Its dysregulation underlies insulin resistance and type 2 diabetes, making it a critical target for research. Advances in CRISPR-based models and biochemical assays continue to illuminate the mechanisms and therapeutic potential of this receptor activity. Understanding insulin receptor activity at the molecular level is essential for developing new treatments for metabolic disease.
References
- 1. Wang X et al.. 2025. Tuning insulin receptor signaling using de novo-designed agonists.. Mol Cell 85(21):4064-4081.e9 PMID: 41086805
- 2. Saltiel AR. 2021. Insulin signaling in health and disease.. J Clin Invest 131(1) PMID: 33393497
- 3. Bak JF. 1994. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.. Dan Med Bull 41(2):179-92 PMID: 8039433
- 4. Sylow L et al.. 2021. The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia.. Cell Metab 33(4):758-780 PMID: 33826918
- 5. Batishchev OV et al.. 2021. Activity-dependent conformational transitions of the insulin receptor-related receptor.. J Biol Chem 296:100534 PMID: 33713705
- 6. Ballotti R et al.. 1989. Insulin receptor: tyrosine kinase activity and insulin action.. Reprod Nutr Dev 29(6):653-61 PMID: 2534271
- 7. Gammeltoft S et al.. 1986. Protein kinase activity of the insulin receptor.. Biochem J 235(1):1-11 PMID: 3017297
- 8. Wu J et al.. 2023. The insulin receptor endocytosis.. Prog Mol Biol Transl Sci 194:79-107 PMID: 36631202
